Off Label Indications – how they are costing your patients?

Off label use is defined as prescribing a medication for a reason that is not officially indicated by Health Canada.  It is common and legal.  Common examples may be the use of amitriptyline for migraine prophylaxis, or the use of gabapentin for neuropathic pain. While they may not have the approved indications by Health Canada, their uses nowadays are almost synonymous with routine clinical practice. But as we move into a national pharmacare, it is important to be more cognizant of which medications (especially expensive ones) are used for off label indications as they may have reimbursement implications.

To manage or contain drug costs, many drug insurance companies may impose various strategies. Common examples include the use of generic medication or dispensing a larger quantity of supply at a time. Almost universally, these strategies help to save on drug costs but do not involve restricting prescribing practices. Prescribers are still liberal in their ability to decide on what options to select for treating specific conditions. However, when insurance companies start imposing any clinical criteria for specific drugs, that is when the freedom to prescribe is affected.

In Ontario where the provincial drug plan is administered via Ontario Drug Benefits program, there are limited use criteria for various medications; special authorizations may be allowed via the Exceptional Access Programme.  They may be aimed to ensure specific drugs are only prescribed in specific conditions. For example,  the use of oral vancomycin is prescribed only when cheaper alternatives (e.g. metronidazole) have been tried, failed or not tolerated.  These cost-containing mechanisms are effective in some ways but may discriminate against specific individuals where a relatively new treatment is being used for a rare condition – so rare that there may be emerging clinical evidence but insufficient to provide a blanket statement for routine recommendation.  For these individuals, they may not have access to these emerging treatments due to lack of routine reimbursement coverage.

Currently many private insurance drug companies may impose some special authorizations for expensive medications. But their clinical criteria are often not as strict as provincial criteria.  As we move forward with National Pharmacare plan, we should not forget this subset population who may require expensive medications for off label use that are currently supported by private insurance coverage. Mechanism should be in place to balance to need to contain costs as well as access to innovative therapies that may not have sufficient time to establish clinical evidence or recommendations.

Do you have any experience with off label use of medication that may be affected by drug coverage challenges? I would love to hear about your experience.

Thank you for reading my post.





Published by


My name is Cynthia Leung and I am a practicing pharmacist in Kingston Ontario, Canada. This blog is for me to share my ideas, opinions and perspectives on how medications are used in our health care system. Note that these posts are my own opinions and do not represent the opinions of my current or former employers and / or organizations that I may belong to. Any possible case scenarios described in my posts would be modified to maintain patient confidentiality. This blog is not a platform for professional advise for patients or health care providers and the content is not meant to support any clinical decisions or replace professional opinions. Also the images are either taken or created by the author, or adapted with permission. I hope you will enjoy reading my posts!

2 thoughts on “Off Label Indications – how they are costing your patients?”

  1. My rheumatologist recently suggested that I try low dose naloxone/natrexone to manage my FM symptoms, which are off-label, experimental use of these drugs. I haven’t yet checked with my insurance if they will cover it… but I am preparing for the battle.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.